Engineered microenvironments and microdevices for modeling the pathophysiology of type 1 diabetes

Area of Science:

• Immunology
• Endocrinology
• Biomedical Engineering

Background:

• Type 1 diabetes (T1D) involves complex immune interactions and beta cell destruction.
• Accurate modeling of T1D pathophysiology is challenging due to its complexity and inter-species differences.
• A gap exists between understanding T1D and developing clinical treatments.

Purpose of the Study:

• To review advances in biomimetic modeling for T1D research.
• To explore the use of biomimetic models in studying islet function and immune responses in T1D.
• To suggest strategies for integrating modeling systems with bioengineered therapeutics.

Main Methods:

• Review of recent literature on biomimetic modeling in type 1 diabetes.
• Analysis of immune cell-islet cell interactions within microenvironments.
• Exploration of bioengineered therapeutic strategies.

Main Results:

• Biomimetic models provide valuable insights into T1D pathophysiology.
• These models facilitate the study and manipulation of islet function.
• They offer a platform for addressing immunological aspects of T1D.

Conclusions:

• Biomimetic modeling is crucial for advancing T1D research.
• Integrating modeling with bioengineered therapies can accelerate clinical translation.
• Further research can bridge the gap between T1D understanding and treatment.